Fractional exhaled breath temperature in patients with asthma, chronic obstructive pulmonary disease, or systemic sclerosis compared to healthy controls.

Asthma COPD fractional exhaled breath temperature healthy systemic sclerosis

Journal

European clinical respiratory journal
ISSN: 2001-8525
Titre abrégé: Eur Clin Respir J
Pays: United States
ID NLM: 101662134

Informations de publication

Date de publication:
2020
Historique:
entrez: 5 5 2020
pubmed: 5 5 2020
medline: 5 5 2020
Statut: epublish

Résumé

Exhaled breath temperature has been suggested to reflect airway inflammation, and it would be plausible to measure the peripheral airway temperature as a correlate to peripheral airway inflammation. This study aims to explore the relative peripheral airway temperature in patients with asthma, chronic obstructive pulmonary disease (COPD) or systemic sclerosis (SSc) compared to healthy controls, and relate to lung function and exhaled nitric oxide. Sixty-five subjects (16 asthmatics, 18 COPD patients, 17 SSc patients and 14 healthy subjects) performed fractional exhaled breath temperature measurements using a novel device, fractional exhaled NO measurements, spirometry, impulse oscillometry, body plethysmography and CO-diffusion capacity test. A significant overall difference among all the patient groups was seen in both the Tmax (= peak values of the entire exhalation) and T3max (= peak value of the last fraction of the exhaled volume). A significant difference in T3/T1 ratio (= the ratio of peripheral versus central air temperature) was found between asthmatic subjects and those with COPD or SSc. In addition, T1max (= temperature in the central), T3max (= peripheral airways) and the T3/T1ratio related to several volumetric measurements (both in absolute values and as percent predicted), such as vital capacity, total lung capacity, forced expiratory volume in 1 s, and diffusion capacity. The temperature ratio of the peripheral versus central airways was lower in patients with COPD or SSc compared to asthmatics, who in turn presented similar levels as the controls. There was also a large overlap between the groups. Overall, the airway temperatures were related to absolute lung volumes, and specifically, the peripheral temperature was related to the gas diffusion capacity (% predicted), suggesting a link to the vascular component.

Identifiants

pubmed: 32363017
doi: 10.1080/20018525.2020.1747014
pii: 1747014
pmc: PMC7178872
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1747014

Informations de copyright

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Références

Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Pediatr Pulmonol. 2016 Jan;51(1):13-21
pubmed: 25917297
J Allergy Clin Immunol. 2013 Mar;131(3):646-57
pubmed: 23380222
Eur Respir J. 2005 Oct;26(4):720-35
pubmed: 16204605
J Bras Pneumol. 2010 Nov-Dec;36(6):693-9
pubmed: 21225171
Respir Med. 2007 Nov;101(11):2321-6
pubmed: 17686621
Am Rev Respir Dis. 1981 Jun;123(6):659-64
pubmed: 7271065
Respir Res. 2005 Feb 10;6:15
pubmed: 15705206
FASEB J. 1998 Aug;12(11):929-37
pubmed: 9707165
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S5-9
pubmed: 21050538
Autoimmun Rev. 2016 May;15(5):417-26
pubmed: 26802722
Int J Tuberc Lung Dis. 2013 Jul;17(7):969-72
pubmed: 23743317
Presse Med. 2014 Oct;43(10 Pt 2):e329-43
pubmed: 25217474
Respirology. 2010 Apr;15(3):459-71
pubmed: 20337993
Eur Respir J. 1993 Oct;6(9):1368-70
pubmed: 7507065
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
Respiration. 2012;84(2):89-97
pubmed: 22868355
Am J Respir Crit Care Med. 2010 Dec 1;182(11):1344-51
pubmed: 20709816
Respiration. 2015;90(2):111-7
pubmed: 26113222
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
J Breath Res. 2014 Sep 18;8(4):046002
pubmed: 25234010
J Appl Physiol (1985). 1998 Aug;85(2):653-66
pubmed: 9688744
Clin Exp Allergy. 2007 Mar;37(3):415-9
pubmed: 17359391
Clin Exp Allergy. 2009 Dec;39(12):1815-21
pubmed: 20085597
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Eur Respir J. 2005 Jul;26(1):52-9
pubmed: 15994389
Pulm Pharmacol Ther. 2013 Apr;26(2):172-9
pubmed: 23073337
Eur Respir J Suppl. 1993 Mar;16:5-40
pubmed: 8499054
J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2 Suppl 1):47-54
pubmed: 26634587

Auteurs

Ellen Tufvesson (E)

Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, Lund University, and Skåne University Hospital Lund, Lund, Sweden.

Erik Nilsson (E)

Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, Lund University, and Skåne University Hospital Lund, Lund, Sweden.

Todor A Popov (TA)

University Hospital Sv. Ivan Rilski, Clinic of Occupational Diseases, Sofia, Bulgaria.

Roger Hesselstrand (R)

Rheumatology, Department of Clinical Sciences Lund, Lund University, and Skåne University Hospital Lund, Lund, Sweden.

Leif Bjermer (L)

Respiratory Medicine and Allergology, Department of Clinical Sciences Lund, Lund University, and Skåne University Hospital Lund, Lund, Sweden.

Classifications MeSH